Kazia Therapeutics (KZIA) Revenue (2011 - 2017)

Kazia Therapeutics' Revenue history runs 6 years deep, the most recent figure standing at $6.6 million for Q2 2017.

• Quarterly Revenue rose 117.76% year-over-year to $6.6 million in Q2 2017, while the trailing twelve-month figure through Jun 2017 was $14.8 million (up 61.23% YoY) and the FY2025 annual result came in at $26898.2, down 98.23% from the prior year.
• Revenue was $6.6 million for Q2 2017 at Kazia Therapeutics, up from $3.1 million in the prior quarter.
• Across five years, Revenue topped out at $6.6 million in Q2 2017 and bottomed at $1.6 million in Q4 2013.
• A 4-year average of $3.3 million and a median of $3.0 million in 2016 frame the typical range for Revenue.
• Annual changes were most pronounced in 2013 — Revenue sank 34.86% — and 2017, when it surged 117.76%.
• Kazia Therapeutics' Revenue stood at $1.6 million in 2013, then grew by 27.43% to $2.0 million in 2015, then surged by 49.31% to $3.1 million in 2016, then soared by 116.76% to $6.6 million in 2017.
• Business Quant data shows KZIA's Revenue at $6.6 million in Q2 2017, $3.1 million in Q4 2016, and $3.0 million in Q2 2016.